Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption. Lopez M, Spehner L, Andre F, Viot J, et al. Breast Cancer Res 2025;27:19.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lopez M, Spehner L, Andre F, Viot J, et al. Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption. Breast Cancer Res 2025;27:19.
PMID: 39920833